Sign in

You're signed outSign in or to get full access.

Andrew Norstrud

Chief Financial Officer at UPEXI
Executive
Board

About Andrew Norstrud

Andrew J. Norstrud is Chief Financial Officer and a Director of Upexi (UPXI). He joined as a consultant in July 2019, became CFO in April 2020, and joined the Board in January 2020. He is 51 years old (2025), holds a BA in Business and Accounting (Western State College) and a Master of Accounting with systems emphasis (University of Florida), and is a Florida-licensed CPA . Company performance during his tenure shows recent quarterly revenue of $9.24M in Q1 2026 with net income of $66.75M, following lower revenue and losses through FY2024, indicating a sharp rebound tied to recent business developments . Historical TSR in the Pay vs Performance table was $67.85 (FY2022) and $36.35 (FY2023) for a $100 initial investment, with net losses those years, contextualizing mixed pay-for-performance alignment .

Past Roles

OrganizationRoleYearsStrategic Impact
GEE Group Inc.CFOMar 2013–Jun 2018Led finance; prior CEO Mar 7, 2014–Apr 1, 2015; director Mar 7, 2014–Aug 16, 2017
Norco Accounting & ConsultingConsultantOct 2011–Mar 2013Advisory for growth-stage public companies
Jagged PeakCFOOct 2005–Oct 2011Built financial team; M&A integration; public company controls
Segmentz, Inc. (XPO Logistics)CFOPrior to Jagged Peak tenureInstrumental in growth initiatives and public company structure
Grant Thornton LLP; PwC LLPAuditor/ConsultantPriorPublic-company financial reporting expertise

External Roles

OrganizationRoleYearsNotes
nDivsion Inc.CFO and DirectorSince Jan 2019Concurrent role noted in 2022 proxy

Fixed Compensation

YearBase Salary ($)Bonus ($)Other ($)Notes
2021210,000 50,000 Options awards $344,900 recognized under ASC 718
2022250,000 200,000 Options awards $476,400 recognized
2023250,000 150,000 30,000 COO listed separately; Norstrud NEO
2024250,000 Accrued and unpaid bonus $375,000 (not in SCT)
2025 (new agreement)350,000 (effective Apr 24, 2025) Quarterly bonus 30–100% of salary (CEO determined) 3-year term, auto-renew 1 year
  • Employment agreement dates and core terms: Feb 1, 2021 agreement (3-year term; auto-renew 1 year; base $250k; annual bonus to be agreed; 388,889 options at $1.53; 10-year term; cashless exercise) . New agreement on Apr 24, 2025 (3-year term; auto-renew 1 year; base $350k; quarterly bonus 30–100%; additional incentive compensation at CEO/Board discretion) . FY2025 10-K confirms term ending Apr 24, 2028 and equity grant terms .

Performance Compensation

Metric/InstrumentWeightingTargetActual/PayoutVesting
Annual bonus (2021–2024 agreements)DiscretionaryCriteria to be agreed by CEO/Comp Committee Examples: $200k (FY2022), $150k (FY2023), accrued $375k (FY2024) N/A
Quarterly bonus (from Apr 24, 2025)Discretionary30%–100% of salary (CEO determined) Paid quarterly; amount at CEO discretion N/A
RS grant (Apr 24, 2025, 100,000 shares)N/AN/AAs of Jun 30, 2025, 20,000 vested, 80,000 unvested 10% per month for 10 months
Stock options (Feb 1, 2021 agreement)N/AN/AOptions outstanding/exercisable per tables below10-year term; monthly vesting noted
  • No explicit quantitative performance metrics (e.g., revenue, EBITDA, TSR) are disclosed as triggers for Norstrud’s bonuses; structure is discretionary and CEO/Committee determined .
  • Equity plan tax and 83(b) guidance included in proxy for participants generally .

Equity Ownership & Alignment

As-of DateShares Beneficially Owned% of ClassComposition/Notes
Jun 20, 202599,138 0.26% 79,138 common; 20,000 restricted stock vesting within 60 days
Apr 19, 20241,061,112 4.92% 305,556 common; 755,556 options exercisable within 60 days

Outstanding Equity Awards

InstrumentQuantityExercise PriceExpirationStatus
Options (as of Jun 30, 2024)10,000 $83.60 7/21/2031 Exercisable
Options (as of Jun 30, 2024)8,334 $30.60 2/1/2031 Exercisable
Options (as of Jun 30, 2024)19,445 $30.60 6/1/2029 Exercisable
RS grant (as of Jun 30, 2025)80,000 unvested; 20,000 vested not issued N/AN/AVests 10,000/month
  • Hedging policy: Company has not adopted a hedging policy for officers/directors (alignment risk) .
  • Pledging: No disclosure found.
  • Ownership guidelines: Not disclosed.
  • Section 16 compliance: Late Form 4 filings noted; Andrew Norstrud filed late on Apr 25, 2025 for transactions dated Apr 17, 2025 (monitor for selling pressure around equity events) .

Employment Terms

AgreementTerm & RenewalBaseVariable PayEquityChange-in-Control/SeveranceCovenants
Norstrud Employment Agreement (Feb 1, 2021) 3-year to Feb 1, 2024; auto 1-year renewal $250,000 Annual bonus (criteria agreed) 388,889 options @ $1.53; 10-year, cashless, vest over 2 years Accelerated option vesting upon Good Reason/CoC subject to Committee approval; lump sum payment equal to 3x base + target bonus + continuation of spouse/dependent benefits (proxy text references “Mr. Marshall” in this clause but context is Norstrud’s agreement) Standard non-compete and confidentiality
Norstrud Employment Agreement (Apr 24, 2025) 3-year to Apr 24, 2028; auto 1-year renewal $350,000 Quarterly 30%–100% of salary (CEO determined); additional incentives at CEO/Board discretion 100,000 RSUs vesting 10% per month for 10 months Standard termination; change-of-control, non-compete and confidentiality (general description) Standard non-compete, confidentiality

Board Governance

  • Role: Director since January 2020; dual role as CFO + Director (non-independent) .
  • Committees: Audit, Compensation, and Nominating & Governance committees exist; membership is fully independent (Salkind, Williams, Dugan). Norstrud not listed as a committee member, mitigating some dual-role independence concerns .
  • Committee activity: Audit met five times in FY2024; Compensation met two times in FY2024; Nominating & Governance at least annually .
  • Director compensation (non-employee): $5,000 per quarterly meeting; $5,000–$7,000 for committee chair; option grants historically to independent directors .

Company Operating Performance (for Pay-for-Performance context)

Metric (USD)Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Revenues7,462,880*5,223,242*5,039,840*4,356,515 4,005,492 3,160,480 4,288,858*9,239,745
EBITDA(1,469,236)*(4,180,795)*(3,549,257)*(1,076,070)*(833,447)*(3,639,517)*(6,462,954)*69,310,367*
Net Income (IS)(2,438,919)*(4,118,612)*(15,745,519)*(1,625,577)*(1,301,310)*(3,831,660)*(6,925,662)*66,748,122

Values with an asterisk were retrieved from S&P Global.

Compensation Structure Analysis

  • Shift to RSUs in 2025: Introduction of 100,000 time-based RS grant vesting over 10 months suggests increased emphasis on retention vs option leverage; options remain in legacy grants at higher strikes (e.g., $83.60, $30.60), which may be out-of-the-money, reducing immediate selling pressure .
  • Increase in guaranteed cash: Base salary increased from $250,000 to $350,000 in Apr 2025, with potential quarterly bonuses up to 100% of salary determined by CEO—greater guaranteed component and discretionary variable pay .
  • Discretionary bonuses: Bonuses historically discretionary and Committee/CEO determined; absence of disclosed quantitative targets limits pay-for-performance transparency .
  • Clawbacks/hedging: No hedging policy adopted; no explicit clawback disclosures identified, an alignment gap relative to best practices .

Risk Indicators & Red Flags

  • Late Section 16 filings: Norstrud filed a late Form 4 on Apr 25, 2025 for transactions dated Apr 17, 2025—monitor for patterns around grants/blackout windows .
  • Hedging policy absent: No anti-hedging policy for officers/directors—potential misalignment risk .
  • Discretionary bonus design: Lack of disclosed performance metrics and CEO-determined quarterly bonus ranges increases subjectivity risk .
  • Equity line and share issuance proposals: 2025 special proxy sought approval for a $500M equity-based line potentially >20% issuance; dilution dynamics may affect long-term alignment of equity awards .

Say-on-Pay & Peer Group

  • Say-on-pay history: Not disclosed in available proxies.
  • Compensation peer group: Not disclosed; committee charters reference use of consultants, but peer selection details not provided .

Expertise & Qualifications

  • Credentials: BA (Western State College), Master of Accounting (University of Florida), Florida CPA .
  • Functional expertise: Public company finance, M&A integration, building controls and teams for high-growth companies; prior CFO roles at Jagged Peak, Segmentz/XPO Logistics, and GEE Group .

Work History & Career Trajectory

OrganizationRoleTenureNotes
Upexi, Inc.CFO; DirectorApr 2020–present; Director since Jan 2020Consultant since Jul 2019 before CFO
GEE Group Inc.CFO; CEO; DirectorCFO Mar 2013–Jun 2018; CEO Mar 7, 2014–Apr 1, 2015; Director Mar 7, 2014–Aug 16, 2017
Jagged PeakCFOOct 2005–Oct 2011Growth and integration
Segmentz, Inc. (XPO Logistics)CFOPriorPublic company structure and acquisitions
Grant Thornton; PwCAudit/ConsultingPriorPublic company reporting
nDivsion Inc.CFO and DirectorSince Jan 2019Concurrent role noted in 2022 proxy

Board Service History and Dual-Role Implications

  • Board service: Director since January 2020 .
  • Committees: Independent directors populate Audit, Compensation, and Nominating & Governance; Norstrud is not on these committees .
  • Independence: As CFO, Norstrud is not independent; however, committee independence and chair roles (Dugan as Audit chair; Salkind as Compensation chair; Williams as Nominating & Governance chair) provide oversight buffers .
  • Attendance: Committee meeting counts (Audit five in FY2024; Compensation two in FY2024) suggest active oversight; specific board attendance rates for Norstrud not disclosed .

Equity Vesting Schedule (Apr 24, 2025 RS Grant)

  • 100,000 shares vest 10% per month for 10 months; as of Jun 30, 2025, 20,000 had vested but not yet issued; 80,000 remained unvested .

Employment & Contracts – Additional Notes

  • The 2021 agreement provides accelerated vesting for options upon certain terminations and change-of-control, with a lump-sum severance formula (3x base + target bonus + benefits); cashless exercise permitted—indicative of retention and transition risk mitigation .
  • FY2025 10-K confirms standard non-compete and confidentiality provisions in the current agreement .

Investment Implications

  • Alignment: Equity shifted to short-duration RSUs vesting over 10 months, increasing near-term retention value but potentially elevating selling pressure as tranches settle; lack of hedging policy and discretionary bonus design are governance gaps investors should monitor .
  • Retention and severance: Enhanced base pay and quarterly bonus structure (30–100% of salary) plus robust severance/change-of-control terms support retention but could raise payout risk in downside scenarios .
  • Trading signals: Late Form 4 in April 2025 and RS vesting cadence (10,000/month) warrant continuous monitoring of insider activity for supply overhang and pre/post blackout timing .
  • Performance linkage: Absence of disclosed quantitative performance metrics in incentive plans reduces pay-for-performance transparency; investors may prefer clearer ties to revenue/EBITDA/TSR thresholds as UPXI transitions to profitability .
  • Governance buffer: Dual role (CFO + Director) is mitigated by fully independent committees and active meeting cadence; nonetheless, independence concerns persist at the full board level given management participation .